Szisztémás szklerózis (szkleroderma): vizsgálatok itt: Ausztrália
12 trials · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Study of AZD0120 in Autoimmune Diseases
- Where
- Clayton, Darlinghurst, Waratah
- Életkor
- 18 év to 75 év
- People
- 27 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07295847 - 3. fázisTaking peopleRollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment
- Where
- Melbourne, Mitcham, Westmead
- Életkor
- 5 év to 80 év
- People
- 1072 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07691970 - 1. fázisTaking peopleA Trial in Healthy Adult Participants and Adults With Autoimmune Diseases to Test How HBM7020 is Tolerated and How it Behaves in the Body
- Where
- Brisbane
- Életkor
- 18 év to 75 év
- People
- 63
- Run by
- Otsuka Pharmaceutical Development & Commercialization, Inc.
See details and how to joinNCT07649265 - 1/2. fázisTaking peopleA Study to Test CRT-402 in Refractory Autoimmune Disease
- Where
- Nedlands
- Életkor
- 18 év and over
- People
- 34
- Run by
- Myeloid Therapeutics
See details and how to joinNCT07778446 - 3. fázisTaking peopleA Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
- Where
- Adelaide, Fitzroy, Westmead
- Életkor
- 18 év and over
- People
- 448 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07497087 · EU 2025-523884-39-00 - 1/2. fázisTaking peopleA Phase 1/2 Study of PRO-203 in Healthy Volunteers and Participants With Systemic Sclerosis.
- Where
- Melbourne
- Életkor
- 18 év to 65 év
- People
- 44 worldwide
- Run by
- Prolium Bioscience, Inc
See details and how to joinNCT07641634 - 2. fázisTaking peopleEncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
- Where
- Heidelberg, Southport, Woolloongabba
- Életkor
- 18 év and over
- People
- 85 worldwide
- Run by
- Mediar Therapeutics
See details and how to joinNCT07287670 - 1. fázisCsak meghívásosA Study of KITE-363 in Participants With Refractory Autoimmune Diseases
- Where
- Fitzroy, Syndey
- Életkor
- 18 év and over
- People
- 52 worldwide
- Run by
- Kite, A Gilead Company
See details and how to joinNCT07038447 - 3. fázisTaking peopleA Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
- Where
- Fitzroy
- Életkor
- 18 év and over
- People
- 514 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06716606 - 2/3. fázisTaking peopleA Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- Where
- Adelaide, Camperdown, Fitzroy, Liverpool, Woodville South
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT05878717 · EU 2023-503219-14-01 - 1. fázisTaking peopleA Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases
- Where
- Melbourne
- Életkor
- 18 év to 75 év
- People
- 60
- Run by
- Xencor, Inc.
See details and how to joinNCT07284797 - 1. fázisTaking peopleA Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
- Where
- Brisbane, Camperdown, Clayton
- Életkor
- 18 év and over
- People
- 125 worldwide
- Run by
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07115745 · EU 2024-517681-41-00